Science Will WinTM
We believe science can cure every human disease. And we're going all in.
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
Global Survey Results: Cancer & Aging
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
THE ANTIGEN: #COVID19 PODCAST
VISIT OUR COVID-19 HUB
Latest News
The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that will be given to Phase 1 participants to evaluate the safety and tolerability of a booster vaccine Discussions with regulatory authorities are ongoing regarding an additional registration-enabling study using an mRNA vaccine with a variant sequence; this would provide a flexible solution for rapidly adapting the vaccine for use against the B.1.351 lineage…